Immuneering to Participate in Jefferies 2021 London Healthcare Conference
November 10, 2021 06:50 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates...